<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Zahar, Jean-Ralph</dc:creator>
  <dc:creator>Poirel, Laurent</dc:creator>
  <dc:creator>Dupont, Claire</dc:creator>
  <dc:creator>Fortineau, Nicolas</dc:creator>
  <dc:creator>Nassif, Xavier</dc:creator>
  <dc:creator>Nordmann, Patrice</dc:creator>
  <dc:date>2015</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">Extended-spectrum β-lactamases producing Escherichia coli (ESBL-E) are increasingly identified in health care facilities. As previously done for the control of methicillin-resistant Staphylococcus aureus, many hospitals have established screening strategies for early identification of patients being carriers of ESBL producers in general and ESBL-E in particular, and have implemented contact precautions (CP) for infected and colonized patients.Methods: The incidence of ESBL-E has been compared retrospectively between two French university hospitals (A and B) with different infection control policies over a 5-year long period of time (2006–2010).Results: While hospital A only implemented standard precautions after identification of patients colonized with ESBL-E, hospital B recommended additional CP. During the period of the study, the ESBL-E incidence rate significantly increased in both hospitals, but no significant difference was observed between the two hospitals.Conclusions: This observational study did not reveal that additional CP measures had a greater impact on the incidence of ESBL-E in hospital settings.</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>https://folia.unifr.ch/global/documents/304676</dc:identifier>
  <dc:identifier>https://folia.unifr.ch/documents/304676/files/nor_auc.pdf</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1186/s12879-015-1244-x</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:rights>License undefined</dc:rights>
  <dc:source>BMC Infectious Diseases. - 2015, vol. 15, p. 512</dc:source>
  <dc:subject xmlns:ns1="xml" ns1:lang="en">ß lactamase</dc:subject>
  <dc:subject xmlns:ns2="xml" ns2:lang="en">Infection control</dc:subject>
  <dc:subject xmlns:ns3="xml" ns3:lang="en">Isolation</dc:subject>
  <dc:subject xmlns:ns4="xml" ns4:lang="en">Hand hygiene</dc:subject>
  <dc:subject>info:eu-repo/classification/udc/616</dc:subject>
  <dc:title xmlns:ns5="xml" ns5:lang="en">About the usefulness of contact precautions for carriers of extended-spectrum beta-lactamase-producing Escherichia coli</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
